Document is current
Any future updates will be listed below
-
Authors
Yasui, Ryota https://orcid.org/0000-0002-5088-7696
Matsui, Atsuka
Sekine, Keisuke https://orcid.org/0000-0001-5133-0876
Okamoto, Satoshi
Taniguchi, Hideki
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development
Ministry of Education, Culture, Sports, Science and Technology of Japan (18K19589)
- License Information
-
More Information
Article History
Accepted: 20 May 2022
First Online: 3 June 2022
Declarations
:
: The use of human iPSC was approved by the ethical committee at Eiken Chemical Co., Ltd., Yokohama City University, and the University of Tokyo.
: Not applicable.
: Not applicable.
: R.Y. and A.M. are employees of Eiken Chemical Co., Ltd. All members conducted research under a collaborative research agreement between Eiken Chemical Co., Ltd., and this research is related to the subject of this article. S.O. and H.T. have served on scientific advisory boards for Healios K.K.
